Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126058401 | 12605840 | 1 | I | 20160612 | 20160729 | 20160729 | PER | US-GLENMARK PHARMACEUTICALS INC, USA.-2016GMK023365 | GLENMARK | GU S, HURLEY H, NEPAL S. IN THE EYE OF THE BEHOLDER: A CASE OF ENDOGENOUS CANDIDAL ENDOPHTHALMITIS DUE TO INTRAVENOUS DRUG ABUSE.. 39TH ANNUAL MEETING OF THE SOCIETY OF GENERAL INTERNAL MEDICINE SGIM 2016. 2016;31 (2 SUPPL. 1):S650 | 0.00 | Y | 0.00000 | 20160729 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126058401 | 12605840 | 1 | SS | FLUCONAZOLE. | FLUCONAZOLE | 1 | Intravenous (not otherwise specified) | UNK | U | 0 | |||||||||
| 126058401 | 12605840 | 2 | SS | FLUCONAZOLE. | FLUCONAZOLE | 1 | Oral | 800 MG, QD | U | 0 | 800 | MG | |||||||
| 126058401 | 12605840 | 3 | PS | LEVOFLOXACIN. | LEVOFLOXACIN | 1 | Intravenous (not otherwise specified) | UNK | U | 200250 | |||||||||
| 126058401 | 12605840 | 4 | C | MOXIFLOXACIN. | MOXIFLOXACIN | 1 | Unknown | UNK | 0 | EYE DROPS | |||||||||
| 126058401 | 12605840 | 5 | C | CYCLOPENTOLATE. | CYCLOPENTOLATE | 1 | Unknown | UNK | 0 | EYE DROPS | |||||||||
| 126058401 | 12605840 | 6 | C | PREDNISOLONE. | PREDNISOLONE | 1 | Unknown | UNK | 0 | EYE DROPS | |||||||||
| 126058401 | 12605840 | 7 | C | VANCOMYCIN | VANCOMYCIN | 1 | Intravenous (not otherwise specified) | 0 | |||||||||||
| 126058401 | 12605840 | 8 | C | CEFTAZIDIM | CEFTAZIDIME | 1 | Intravenous (not otherwise specified) | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126058401 | 12605840 | 1 | Candida endophthalmitis |
| 126058401 | 12605840 | 3 | Candida endophthalmitis |
| 126058401 | 12605840 | 4 | Candida endophthalmitis |
| 126058401 | 12605840 | 5 | Candida endophthalmitis |
| 126058401 | 12605840 | 6 | Candida endophthalmitis |
| 126058401 | 12605840 | 7 | Candida endophthalmitis |
| 126058401 | 12605840 | 8 | Candida endophthalmitis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126058401 | 12605840 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126058401 | 12605840 | Drug ineffective | |
| 126058401 | 12605840 | Product use issue |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |